BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33264072)

  • 1. Polysulfated Hyaluronan GlycoMira-1111 Inhibits Elastase and Improves Rheology in Cystic Fibrosis Sputum.
    Kummarapurugu AB; Zheng S; Pulsipher A; Savage JR; Ma J; Rubin BK; Kennedy TP; Voynow JA
    Am J Respir Cell Mol Biol; 2021 Feb; 64(2):260-267. PubMed ID: 33264072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis.
    Kummarapurugu AB; Afosah DK; Sankaranarayanan NV; Navaz Gangji R; Zheng S; Kennedy T; Rubin BK; Voynow JA; Desai UR
    J Biol Chem; 2018 Aug; 293(32):12480-12490. PubMed ID: 29903912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.
    Broughton-Head VJ; Shur J; Carroll MP; Smith JR; Shute JK
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1240-9. PubMed ID: 17827252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients.
    Morla S; Sankaranarayanan NV; Afosah DK; Kumar M; Kummarapurugu AB; Voynow JA; Desai UR
    J Med Chem; 2019 Jun; 62(11):5501-5511. PubMed ID: 31074986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
    Hansen G; Hoffjan S; Mosler K; Schuster A
    Lung; 2001; 179(3):185-94. PubMed ID: 11891608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro.
    Rubin BK; Kater AP; Goldstein AL
    Chest; 2006 Nov; 130(5):1433-40. PubMed ID: 17099021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis.
    Bryson HM; Sorkin EM
    Drugs; 1994 Dec; 48(6):894-906. PubMed ID: 7533697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
    Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
    Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.
    Voynow JA; Zheng S; Kummarapurugu AB
    Front Pharmacol; 2020; 11():1011. PubMed ID: 32733248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of DNA and actin polymers on the polymer structure and rheology of cystic fibrosis sputum and depolymerization by gelsolin or thymosin beta 4.
    Kater A; Henke MO; Rubin BK
    Ann N Y Acad Sci; 2007 Sep; 1112():140-53. PubMed ID: 17496063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy.
    Papayannopoulos V; Staab D; Zychlinsky A
    PLoS One; 2011; 6(12):e28526. PubMed ID: 22174830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
    Goa KL; Lamb H
    Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
    Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
    Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis.
    Shah PL; Scott SF; Knight RA; Hodson ME
    Eur Respir J; 1996 Mar; 9(3):531-4. PubMed ID: 8730015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-O, 3-O-desulfated heparin inhibits neutrophil elastase-induced HMGB-1 secretion and airway inflammation.
    Griffin KL; Fischer BM; Kummarapurugu AB; Zheng S; Kennedy TP; Rao NV; Foster WM; Voynow JA
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):684-9. PubMed ID: 24325600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis.
    Dittrich AS; Kühbandner I; Gehrig S; Rickert-Zacharias V; Twigg M; Wege S; Taggart CC; Herth F; Schultz C; Mall MA
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29545279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
    Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
    Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.